Marisa S Klein-Gitelman
Overview
Explore the profile of Marisa S Klein-Gitelman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
61
Citations
864
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Khojah A, Morgan G, Kadakia A, Klein-Gitelman M, Pachman L
Sci Rep
. 2024 Nov;
14(1):26528.
PMID: 39489760
This study investigates the prevalence of dyslipidemia and its association with disease activity in children with Juvenile Dermatomyositis (JDM). A retrospective chart review of 142 JDM patients who had fasting...
2.
Ogbu E, Sagcal-Gironella A, Eberhard B, Huggins J, Klein-Gitelman M, Onel K, et al.
ACR Open Rheumatol
. 2024 Oct;
7(1):e11737.
PMID: 39468386
Objective: We compared the measurement properties of a traditional physician global assessment of disease activity (PhGA) 10-cm visual analog scale (PhGA) with that of the three-point numeric scale (PhGA) in...
3.
Weiss P, Brandon T, Aggarwal A, Burgos-Vargas R, Colbert R, Horneff G, et al.
Arthritis Rheumatol
. 2024 Jul;
76(12):1797-1808.
PMID: 39039899
Objective: The goal was to develop and validate classification criteria for axial juvenile spondyloarthritis (SpA; AxJSpA). Methods: This international initiative consisted of four phases: (1) item generation, (2) item reduction,...
4.
Saper V, Tian L, Verstegen R, Conrad C, Cidon M, Hopper R, et al.
J Allergy Clin Immunol Pract
. 2024 Jul;
12(11):2996-3013.e7.
PMID: 39002722
Background: After introducing IL-1/IL-6 inhibitors, some patients with Still and Still-like disease developed unusual, often fatal, pulmonary disease. This complication was associated with scoring as DReSS (drug reaction with eosinophilia...
5.
Khojah A, Pachman L, Bukhari A, Trinh C, Morgan G, Pandey S, et al.
Int J Mol Sci
. 2024 Jul;
25(13.
PMID: 39000234
Juvenile Dermatomyositis (JDM) is the most common inflammatory myopathy in pediatrics. This study evaluates the role of Natural Killer (NK) cells in Juvenile Dermatomyositis (JDM) pathophysiology. The study included 133...
6.
Tarvin S, Sherman M, Kim H, Balmuri N, Brown A, Chow A, et al.
Arthritis Care Res (Hoboken)
. 2024 Jun;
76(11):1532-1539.
PMID: 38937134
Objective: The objective was to develop consensus treatment plans (CTPs) for patients with refractory moderately severe juvenile dermatomyositis (JDM) treated with biologic disease-modifying antirheumatic drugs (bDMARDs). Methods: The Biologics Workgroup...
7.
Correll C, Klein-Gitelman M, Henrickson M, Battafarano D, Orr C, Leonard M, et al.
Pediatrics
. 2024 Feb;
153(Suppl 2).
PMID: 38300008
The Pediatric Rheumatology (PRH) workforce supply in the United States does not meet the needs of children. Lack of timely access to PRH care is associated with poor outcomes for...
8.
Khojah A, Morgan G, Klein-Gitelman M, Pachman L
Pediatr Rheumatol Online J
. 2023 Nov;
21(1):137.
PMID: 37957619
Background: Juvenile Dermatomyositis (JDM) is a rare autoimmune disease characterized by skin and muscle inflammation. The loss of nail fold capillary end row loops (ERL) is evidence of small vessel...
9.
Pachman L, Morgan G, Klein-Gitelman M, Ahsan N, Khojah A
Pediatr Rheumatol Online J
. 2023 Oct;
21(1):118.
PMID: 37828536
Background: We lack a reliable indicator of disease activity in Juvenile Dermatomyositis (JDM), a rare disease. The goal of this study is to identify the association of nailfold capillary End...
10.
Khojah A, Morgan G, Klein-Gitelman M, Pachman L
Res Sq
. 2023 Sep;
PMID: 37674726
Background: Juvenile Dermatomyositis (JDM) is a rare autoimmune disease characterized by skin and muscle inflammation. The loss of nail fold capillary end row loops (ERL) is evidence of small vessel...